These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 689948

  • 21. [Hormone-therapy of carcinoma of the breast].
    Villani C, Mazzon I.
    Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505
    [No Abstract] [Full Text] [Related]

  • 22. Current status of estrogen and progesterone receptors in breast cancer.
    McGuire WL, Horwitz KB, Pearson OH, Segaloff A.
    Cancer; 1977 Jun; 39(6 Suppl):2934-47. PubMed ID: 326386
    [Abstract] [Full Text] [Related]

  • 23. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R.
    Cancer Res; 1979 Jun; 39(6 Pt 1):1973-9. PubMed ID: 445396
    [Abstract] [Full Text] [Related]

  • 24. Endocrine manipulation in the treatment of breast cancer.
    Segaloff A.
    Clin Obstet Gynecol; 1975 Jun; 18(2):227-37. PubMed ID: 166781
    [No Abstract] [Full Text] [Related]

  • 25. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E, Veldhuis JD, Wells SA, Santen RJ.
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [Abstract] [Full Text] [Related]

  • 26. [The endocrine profile in prostatic cancer: therapeutic implications].
    Calvo Mateo MA, Castellanos Llorens JM, Galán Ortega A.
    Actas Urol Esp; 1981 Mar; 5(1):3-12. PubMed ID: 7015803
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Biochemical basis for the selection of hormonal manipulation in the patient with breast carcinoma.
    Wittliff JL, Savlov ED.
    Int J Radiat Oncol Biol Phys; 1978 Mar; 4(5-6):463-7. PubMed ID: 689947
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Could aminoglutethimide replace adrenalectomy?
    Harris AL.
    Breast Cancer Res Treat; 1985 Mar; 6(3):201-11. PubMed ID: 3912013
    [Abstract] [Full Text] [Related]

  • 32. [Medical treatment of the breast].
    Battelli T, Manocchi P, Guistini L, Mattioli R, Ginnetti A.
    Minerva Med; 1984 Feb 18; 75(6):227-33. PubMed ID: 6231491
    [No Abstract] [Full Text] [Related]

  • 33. Solving the puzzle of hormone-dependent breast cancer.
    Santen RJ.
    Trans Am Clin Climatol Assoc; 1992 Feb 18; 103():164-75. PubMed ID: 1413376
    [No Abstract] [Full Text] [Related]

  • 34. [Hormonal treatment of breast tumor].
    Garcia Giralt E, Omodei Zorini C.
    Clin Ter; 1990 Feb 28; 132(4):217-27. PubMed ID: 2140308
    [No Abstract] [Full Text] [Related]

  • 35. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G, Heuson JC.
    Biochim Biophys Acta; 1979 Dec 19; 560(4):427-55. PubMed ID: 391285
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.